Literature DB >> 7664344

Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3.

C R Wang1, A R Castaño, P A Peterson, C Slaughter, K F Lindahl, J Deisenhofer.   

Abstract

H2-M3 is a class Ib MHC molecule of the mouse with a 10(4)-fold preference for binding N-formylated peptides. To elucidate the basis of this unusual specificity, we expressed and crystallized a soluble form of M3 with a formylated nonamer peptide, fMYFINILTL, and determined the structure by X-ray crystallography. M3, refined at 2.1 A resolution, resembles class la MHC molecules in its overall structure, but differs in the peptide-binding groove. The A pocket, which usually accommodates the free N-terminus of a bound peptide, is closed, and the peptide is shifted one residue, such that the P1 side chain is lodged in the B pocket. The formyl group is coordinated by His-9 and a bound water on the floor of the groove.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664344     DOI: 10.1016/0092-8674(95)90037-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  35 in total

1.  Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Authors:  Charles L Dulberger; Curtis P McMurtrey; Angelique Hölzemer; Karlynn E Neu; Victor Liu; Adriana M Steinbach; Wilfredo F Garcia-Beltran; Michael Sulak; Bana Jabri; Vincent J Lynch; Marcus Altfeld; William H Hildebrand; Erin J Adams
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

2.  Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors.

Authors:  Erin J Adams; Z Sean Juo; Rayna Takaki Venook; Martin J Boulanger; Hisashi Arase; Lewis L Lanier; K Christopher Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-30       Impact factor: 11.205

3.  Species-specific class I gene expansions formed the telomeric 1 mb of the mouse major histocompatibility complex.

Authors:  Toyoyuki Takada; Attila Kumánovics; Claire Amadou; Masayasu Yoshino; Elsy P Jones; Maria Athanasiou; Glen A Evans; Kirsten Fischer Lindahl
Journal:  Genome Res       Date:  2003-04       Impact factor: 9.043

Review 4.  Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules.

Authors:  Daisuke Morita; Masahiko Sugita
Journal:  Immunology       Date:  2016-08-10       Impact factor: 7.397

5.  MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.

Authors:  Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

6.  Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.

Authors:  Q R Fan; D C Wiley
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

7.  Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Elena Merino; José A López de Castro; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

Review 8.  The role of MHC class Ib-restricted T cells during infection.

Authors:  Courtney K Anderson; Laurent Brossay
Journal:  Immunogenetics       Date:  2016-07-01       Impact factor: 2.846

9.  Cotton rat Sihi-M3 is a minimally oligomorphic Mhc I-b molecule that binds the chemotactic peptide fMLF under stringent conditions. Evidence that positive selection drives inter-species diversity of residues interacting with the termini of short peptides.

Authors:  C Kuyler Doyle; Richard G Cook; Robert R Rich; John R Rodgers
Journal:  Immunogenetics       Date:  2003-08-27       Impact factor: 2.846

10.  The Listeria monocytogenes lemA gene product is not required for intracellular infection or to activate fMIGWII-specific T cells.

Authors:  Sarah E F D'Orazio; Marisela Velasquez; Nadia R Roan; Olaia Naveiras-Torres; Michael N Starnbach
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.